Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Gomez-Rosas P, Giaccherini C, Russo L, Verzeroli C, Gamba S, Tartari CJ, Bolognini S, Ticozzi C, Schieppati F, Barcella L, Sarmiento R, Masci G, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Minelli M, De Braud F, Santoro A, Labianca R, Gasparini G, Marchetti M, Falanga A, On Behalf Of The Hypercan Investigators. Gomez-Rosas P, et al. Among authors: barcella l. Cancers (Basel). 2023 Sep 15;15(18):4588. doi: 10.3390/cancers15184588. Cancers (Basel). 2023. PMID: 37760562 Free PMC article.
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study.
Schieppati F, Russo L, Marchetti M, Barcella L, Cefis M, Gomez-Rosas P, Caldara G, Carpenedo M, D'Adda M, Rambaldi A, Savignano C, Billio A, Bruno Franco M, Toschi V, Falanga A. Schieppati F, et al. Among authors: barcella l. Am J Hematol. 2020 Aug;95(8):953-959. doi: 10.1002/ajh.25845. Epub 2020 May 21. Am J Hematol. 2020. PMID: 32350923 Free article.
Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.
Schieppati F, Russo L, Gamba S, Galimberti E, Giaccherini C, Tartari CJ, Bolognini S, Verzeroli C, Ticozzi C, Barcella L, Marchetti M, Falanga A. Schieppati F, et al. Among authors: barcella l. Thromb Haemost. 2023 Oct;123(10):945-954. doi: 10.1055/s-0043-1768921. Epub 2023 May 12. Thromb Haemost. 2023. PMID: 37172940
External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G. Tosetto A, et al. Among authors: barcella l. J Thromb Haemost. 2017 Oct;15(10):1963-1970. doi: 10.1111/jth.13781. Epub 2017 Aug 23. J Thromb Haemost. 2017. PMID: 28762665 Free article.
Clozapine-induced anemia: A case-report
.
Eleftheriou G, Butera R, Barcella L, Falanga A. Eleftheriou G, et al. Among authors: barcella l. Int J Clin Pharmacol Ther. 2020 May;58(5):289-292. doi: 10.5414/CP203679. Int J Clin Pharmacol Ther. 2020. PMID: 32145755
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
Mancini I, Agosti P, Boscarino M, Ferrari B, Artoni A, Palla R, Spreafico M, Crovetti G, Volpato E, Rossini S, Novelli C, Gattillo S, Barcella L, Salmoiraghi M, Falanga A, Peyvandi F; Lombardy AREU TMA Network. Mancini I, et al. Among authors: barcella l. Orphanet J Rare Dis. 2022 Jun 23;17(1):246. doi: 10.1186/s13023-022-02400-y. Orphanet J Rare Dis. 2022. PMID: 35739601 Free PMC article.
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
24 results